Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers
source: pixabay.com

Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers

A recent BioSpace press release shares some exciting news for patients with non-small cell lung cancer, medullary thyroid cancer, and other thyroid cancers caused by RET gene mutations. Retevmo (selpercatinib) is the…

Continue Reading Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers
UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer
source: pixabay.com

UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer

  Immunotherapies are in the forefront for treating autoimmune diseases and cancer. Northwestern University and the University of California San Francisco conducted a study using genes that have the potential…

Continue Reading UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer
UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer
source: pixabay.com

UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer

  Immunotherapies are in the forefront for treating autoimmune diseases and cancer. Northwestern University and the University of California San Francisco conducted a study using genes that have the potential…

Continue Reading UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer
Industry Leaders Team Up to Advocate for Rare Disease Patients Despite the COVID-19 Pandemic
source: pixabay.com

Industry Leaders Team Up to Advocate for Rare Disease Patients Despite the COVID-19 Pandemic

By Natalie Homan from In The Cloud Copy Two businesses that advocate for patients with rare and orphan diseases announced recently that they are teaming up to help patients get…

Continue Reading Industry Leaders Team Up to Advocate for Rare Disease Patients Despite the COVID-19 Pandemic
Company Raises $14 Million Towards Sanfilippo Syndrome and Other Rare Disease Research
source: pixabay.com

Company Raises $14 Million Towards Sanfilippo Syndrome and Other Rare Disease Research

According to a story from Sanfilippo News, the healthcare tech company RDMD has recently announced that it has raised $14 million in Series A financing that will be dedicated towards…

Continue Reading Company Raises $14 Million Towards Sanfilippo Syndrome and Other Rare Disease Research